ID
32734
Beschreibung
Study ID: 109059 Clinical Study ID: OTB109059 Study Title: TXA107979:A Phase II Study to Evaluate: Delay in Intravaginal Ejaculatory Latency Time (IELT), Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Oral Doses of GSK557296 in a Randomized, Double Blind, Placebo-Controlled, Parallel Group Study in Men with Premature Ejaculation Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01021553 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: epelsiban Trade Name: Study Indication: Premature Ejaculation
Stichworte
Versionen (1)
- 13.11.18 13.11.18 -
Rechteinhaber
GlaxoSmithKline
Hochgeladen am
13. November 2018
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 3.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Delay in IELT, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK557296 in Men with Premature Ejaculation, 109059
IP Compliance
- StudyEvent: ODM
Beschreibung
IP Compliance Dispensed
Alias
- UMLS CUI-1
- C0304229
- UMLS CUI-2
- C1321605
- UMLS CUI-3
- C1880359
Beschreibung
Experimental Drug, Dispense, Date in time
Datentyp
date
Alias
- UMLS CUI [1,1]
- C0304229
- UMLS CUI [1,2]
- C1880359
- UMLS CUI [1,3]
- C0011008
Beschreibung
Experimental Drug, Blister Pack, First, Number
Datentyp
integer
Alias
- UMLS CUI [1,1]
- C0304229
- UMLS CUI [1,2]
- C1706080
- UMLS CUI [1,3]
- C0205435
- UMLS CUI [1,4]
- C0237753
Beschreibung
Experimental Drug, Dispense, Blister Pack, First, Count of entities
Datentyp
integer
Alias
- UMLS CUI [1,1]
- C0304229
- UMLS CUI [1,2]
- C1880359
- UMLS CUI [1,3]
- C1706080
- UMLS CUI [1,4]
- C0205435
- UMLS CUI [1,5]
- C0449788
Beschreibung
Experimental Drug, Blister Pack, Second, Number
Datentyp
integer
Alias
- UMLS CUI [1,1]
- C0304229
- UMLS CUI [1,2]
- C1706080
- UMLS CUI [1,3]
- C0205436
- UMLS CUI [1,4]
- C0237753
Beschreibung
Experimental Drug, Dispense, Blister Pack, Second, Count of entities
Datentyp
integer
Alias
- UMLS CUI [1,1]
- C0304229
- UMLS CUI [1,2]
- C1880359
- UMLS CUI [1,3]
- C1706080
- UMLS CUI [1,4]
- C0205436
- UMLS CUI [1,5]
- C0449788
Ähnliche Modelle
IP Compliance
- StudyEvent: ODM
C1321605 (UMLS CUI-2)
C0332156 (UMLS CUI-3)
C0332156 (UMLS CUI [1,2])
C1880359 (UMLS CUI [1,3])
C0332156 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C1706080 (UMLS CUI [1,2])
C0205435 (UMLS CUI [1,3])
C0237753 (UMLS CUI [1,4])
C1706080 (UMLS CUI [1,2])
C0205435 (UMLS CUI [1,3])
C0449788 (UMLS CUI [1,4])
C0332156 (UMLS CUI [1,5])
C1880359 (UMLS CUI [1,2])
C1706080 (UMLS CUI [1,3])
C0205436 (UMLS CUI [1,4])
C0237753 (UMLS CUI [1,5])
C1706080 (UMLS CUI [1,2])
C0205436 (UMLS CUI [1,3])
C0449788 (UMLS CUI [1,4])
C0332156 (UMLS CUI [1,5])
C1290952 (UMLS CUI [1,2])
C1290952 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,3])
C1321605 (UMLS CUI-2)
C1880359 (UMLS CUI-3)
C1880359 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C1706080 (UMLS CUI [1,2])
C0205435 (UMLS CUI [1,3])
C0237753 (UMLS CUI [1,4])
C1880359 (UMLS CUI [1,2])
C1706080 (UMLS CUI [1,3])
C0205435 (UMLS CUI [1,4])
C0449788 (UMLS CUI [1,5])
C1706080 (UMLS CUI [1,2])
C0205436 (UMLS CUI [1,3])
C0237753 (UMLS CUI [1,4])
C1880359 (UMLS CUI [1,2])
C1706080 (UMLS CUI [1,3])
C0205436 (UMLS CUI [1,4])
C0449788 (UMLS CUI [1,5])
Keine Kommentare